πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8372873

Inhibitors of serine proteases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8372850

Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8372846

Co-crystals and pharmaceutical compositions comprising the same

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8372835

Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367690

Aminopyridine derivatives having aurora a selective inhibitory action

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367697

Kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367691

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367660

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8362043

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8362253

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8362032

Bicyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8357718

Compounds and methods for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated Β· Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8357702

Bicyclic derivatives as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8354419

Benzimidazole analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8354427

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8350077

Amides of creatine, method of their preparation, and remedy possessing a neuroprotective a

Vertex Closed Joint Stock Company Β· Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8344147

Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8344153

Inhibitors of phosphatidylinositol 3-kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8343998

Triazolothiadiazole inhibitor of c-Met protein kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8343980

Quinazoles useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8343763

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8338597

Pyridones useful as inhibitors of kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8338412

Inhibitors of P38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8329662

Prodrug of an ICE inhibitor

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted